These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Circulation; 2006 Feb 14; 113(6):776-82. PubMed ID: 16461817 [Abstract] [Full Text] [Related]
3. Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. Kadish A, Schaechter A, Subacius H, Thattassery E, Sanders W, Anderson KP, Dyer A, Goldberger J, Levine J. J Am Coll Cardiol; 2006 Jun 20; 47(12):2477-82. PubMed ID: 16781376 [Abstract] [Full Text] [Related]
4. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. N Engl J Med; 2004 May 20; 350(21):2151-8. PubMed ID: 15152060 [Abstract] [Full Text] [Related]
5. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy. Verma A, Sarak B, Kaplan AJ, Oosthuizen R, Beardsall M, Wulffhart Z, Higenbottam J, Khaykin Y. Pacing Clin Electrophysiol; 2010 Mar 20; 33(3):320-9. PubMed ID: 19796352 [Abstract] [Full Text] [Related]
8. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Dickinson MG, Ip JH, Olshansky B, Hellkamp AS, Anderson J, Poole JE, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators. Am Heart J; 2007 Apr 20; 153(4):573-8. PubMed ID: 17383296 [Abstract] [Full Text] [Related]
9. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators. Chen HA, Hsia HH, Vagelos R, Fowler M, Wang P, Al-Ahmad A. Pacing Clin Electrophysiol; 2007 Mar 20; 30(3):390-4. PubMed ID: 17367359 [Abstract] [Full Text] [Related]
10. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F, ALPHA Study Group Investigators. J Am Coll Cardiol; 2007 Nov 06; 50(19):1896-904. PubMed ID: 17980258 [Abstract] [Full Text] [Related]
11. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker JH, Sethuraman B, Dettmer MM, Rosenbaum DS, ABCD Trial Investigators. J Am Coll Cardiol; 2009 Feb 10; 53(6):471-9. PubMed ID: 19195603 [Abstract] [Full Text] [Related]
12. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT. Grimm W, Alter P, Maisch B. Herz; 2004 May 10; 29(3):348-52. PubMed ID: 15167963 [Abstract] [Full Text] [Related]
14. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Noyes K, Corona E, Zwanziger J, Hall WJ, Zhao H, Wang H, Moss AJ, Dick AW, Multicenter Automatic Defibrillator Implantation Trial II. Med Care; 2007 May 10; 45(5):377-85. PubMed ID: 17446823 [Abstract] [Full Text] [Related]
15. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697 [Abstract] [Full Text] [Related]
16. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. Goldberger JJ, Subacius H, Schaechter A, Howard A, Berger R, Shalaby A, Levine J, Kadish AH, DEFINITE Investigators. J Am Coll Cardiol; 2006 Sep 19; 48(6):1228-33. PubMed ID: 16979011 [Abstract] [Full Text] [Related]
19. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death. Klein MH, Gold MR. Cardiol Clin; 2008 Aug 19; 26(3):419-31, vi-vii. PubMed ID: 18538188 [Abstract] [Full Text] [Related]
20. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. Olshansky B, Poole JE, Johnson G, Anderson J, Hellkamp AS, Packer D, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators. J Am Coll Cardiol; 2008 Apr 01; 51(13):1277-82. PubMed ID: 18371559 [Abstract] [Full Text] [Related] Page: [Next] [New Search]